Meta-analysis

Association between the ERCC2 rs13181 polymorphism and the risk of glioma: a meta-analysis

T. L. Jia, Wu, H. J., Wang, H. B., Ma, W. B., and Xing, B., Association between the ERCC2 rs13181 polymorphism and the risk of glioma: a meta-analysis, vol. 14, pp. 12577-12584, 2015.

Several studies have focused on the association between the ERCC2 rs13181 polymorphism and glioma risk, but the results were inconclusive. We aimed to conduct a meta-analysis to investigate the role of ERCC2 rs13181 on the risk of glioma. We searched and collated the relevant studies in both Chinese and English through the PubMed, Web of Science, Cochrane Library, and EMBASE databases published through June 1, 2014. A total of 11 studies for ERCC2 rs13181 were selected; these included 3456 glioma cases and 4957 controls.

Subscribe to Meta-analysis